Rodman & Renshaw Initiates Coverage on Kyverna Therapeutics (NASDAQ:KYTX)
Equities researchers at Rodman & Renshaw began coverage on shares of Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. The firm set a “buy” rating and a $16.00 price target on the stock. Rodman & Renshaw’s price target points to a potential upside […]
More Stories
Standard Motor Products, Inc. (NYSE:SMP) Short Interest Down 43.8% in September
Standard Motor Products, Inc. (NYSE:SMP – Get Free Report) saw a significant drop in short interest in the month of...
Short Interest in Mercedes-Benz Group AG (OTCMKTS:MBGYY) Declines By 44.5%
Mercedes-Benz Group AG (OTCMKTS:MBGYY – Get Free Report) saw a large decrease in short interest during the month of September....
Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Declines By 44.7%
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC – Get Free Report) was the target of a large drop in short interest during...
Congress Park Capital LLC Has $284,000 Stock Position in Reddit, Inc. (NYSE:RDDT)
Congress Park Capital LLC lowered its stake in Reddit, Inc. (NYSE:RDDT – Free Report) by 21.3% during the third quarter,...
Guild Investment Management Inc. Purchases Shares of 12,400 Alibaba Group Holding Limited (NYSE:BABA)
Guild Investment Management Inc. acquired a new stake in Alibaba Group Holding Limited (NYSE:BABA – Free Report) in the 3rd...
3,297 Shares in The Toronto-Dominion Bank (NYSE:TD) Acquired by Successful Portfolios LLC
Successful Portfolios LLC acquired a new position in The Toronto-Dominion Bank (NYSE:TD – Free Report) (TSE:TD) in the 3rd quarter,...